Published in Chest on November 01, 1993
Clinical utility of thoracoscopy. Chest (1992) 6.34
Mediastinoscopy as a standardised procedure for mediastinal lymph node staging in non-small cell lung carcinoma. Eur J Cardiothorac Surg (2001) 2.61
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (1988) 2.47
Current aspects of spontaneous pneumothorax. Eur Respir J (1997) 2.29
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol (1998) 2.15
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma. J Clin Oncol (1998) 2.11
Dextrocardia? Chest (1989) 2.08
Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med (2000) 2.06
Interatrial right-to-left shunting developing after pulmonary resection in the absence of elevated right-sided heart pressures. Review of the literature. Chest (1993) 2.02
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J (2009) 2.01
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil. Eur Respir J (2010) 1.63
Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study. Eur Respir J (2002) 1.62
Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol (1989) 1.59
Spontaneous pneumothorax: predictable mini-epidemics? Lancet (1997) 1.59
Molecular pathology of non-small-cell lung cancer. Respiration (2005) 1.56
Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest (1997) 1.54
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group. Eur J Cancer (1997) 1.52
Cost-effectiveness of video-assisted thoracoscopic surgery versus conservative treatment for first time or recurrent spontaneous pneumothorax. Eur Respir J (1996) 1.51
Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation (2009) 1.51
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer. J Clin Oncol (1999) 1.43
[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. Ned Tijdschr Geneeskd (2008) 1.43
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol (1998) 1.42
Comparison of the respiratory and hemodynamic responses of healthy subjects to exercise in three different protocols. Occup Med (Lond) (1996) 1.41
Untreated idiopathic aneurysm of the pulmonary artery; long-term follow-up. Respir Med (2000) 1.40
A pyrrhic victory in small cell lung cancer. Chest (1989) 1.39
[The diagnosis of pulmonary embolism: the best strategies according to the results of a large Dutch multicentre study]. Ned Tijdschr Geneeskd (2005) 1.38
Acute and cumulative effects of carboplatin on renal function. Br J Cancer (1989) 1.33
RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol (2009) 1.33
[Two patients with a rare manifestation of amyloidosis in the respiratory system]. Ned Tijdschr Geneeskd (2007) 1.32
Atmospheric pressure changes and outdoor temperature changes in relation to spontaneous pneumothorax. Chest (1999) 1.32
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2009) 1.32
Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res (1999) 1.31
The arterial load in pulmonary hypertension. Eur Respir Rev (2010) 1.28
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res (1985) 1.28
Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br J Cancer (2011) 1.27
Bronchoscopic treatment of intraluminal typical carcinoid: a pilot study. J Thorac Cardiovasc Surg (1998) 1.27
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre. J Clin Oncol (1997) 1.25
Granular cell tumors of the tracheobronchial tree. J Thorac Cardiovasc Surg (2003) 1.25
Videothoracoscopic appearance of first and recurrent pneumothorax. Chest (1995) 1.24
Outcome of bronchial carcinoma in situ. Chest (2000) 1.23
Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J (2006) 1.23
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol (1997) 1.22
Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI. Chest (2001) 1.19
Ventilation and perfusion imaging by electrical impedance tomography: a comparison with radionuclide scanning. Physiol Meas (1998) 1.19
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol (1993) 1.18
Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J (2010) 1.17
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment. Eur J Cancer (2011) 1.16
Electrical impedance tomography to measure pulmonary perfusion: is the reproducibility high enough for clinical practice? Physiol Meas (2003) 1.16
ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study. Ann Oncol (2003) 1.14
Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Cancer Res (1999) 1.14
Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung Cancer (2005) 1.13
Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res (1985) 1.11
A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer. Br J Cancer (1998) 1.11
Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism. Am J Respir Crit Care Med (2000) 1.09
Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res (1988) 1.08
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol (2010) 1.07
Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review. J Clin Oncol (2000) 1.06
The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema. Chest (1997) 1.05
A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes. Cell Oncol (2009) 1.05
Combination chemotherapy studies with gemcitabine. Semin Oncol (1997) 1.04
Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann Oncol (2001) 1.04
Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J (2007) 1.03
Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique. Eur Respir J (1998) 1.02
Tracheobronchial stenting in the terminal care of cancer patients with central airways obstruction. Chest (2001) 1.02
Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest (1995) 1.01
Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose? Lung Cancer (2001) 0.99
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule. J Clin Oncol (1999) 0.99
Endoscopic management of bronchial stenosis after double lung transplantation. Chest (1992) 0.98
Asthma genetics and intermediate phenotypes: a review from twin studies. Twin Res (2001) 0.97
A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations. Cell Oncol (2009) 0.97
Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. J Allergy Clin Immunol (1998) 0.97
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatment. Br J Cancer (2005) 0.97
High-dose etoposide for refractory malignancies: a phase I study. Cancer Treat Rep (1984) 0.96
Endobronchial lipoma: a series of three cases and the role of electrocautery. Respiration (2000) 0.95
A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax (1989) 0.95
Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis (2008) 0.95
Surgical resection for small cell carcinoma of the lung: a retrospective study. Thorax (1994) 0.94
Treatment of patients with spontaneous pneumothorax during videothoracoscopy. Eur Respir J (1994) 0.94
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group. J Thorac Oncol (2006) 0.92
A phase II study of high dose epirubicin in unresectable non small cell lung cancer. Br J Cancer (1992) 0.91
Improved diagnosis of carcinoid tumors by measurement of platelet serotonin. Clin Chem (1992) 0.91
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer. Lung Cancer (2001) 0.91
Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice. Eur J Cancer (1999) 0.91
Late onset asthma? Eur Respir J (1991) 0.91
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines. Biochem Pharmacol (1999) 0.90
NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J (2006) 0.90
Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer. Eur J Cancer (1993) 0.90
Single-agent gemcitabine in patients with resistant small-cell lung cancer. Ann Oncol (2001) 0.90
Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals. Thorax (2002) 0.89
Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncol (1996) 0.89
Pulmonary nodules in a patient with seminoma testis. Chest (1996) 0.89
Pulmonary perfusion measured by means of electrical impedance tomography. Physiol Meas (1998) 0.89
A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research. Pflugers Arch (2007) 0.89
Genetic and environmental influences on objective intermediate asthma phenotypes in Dutch twins. Eur Respir J (2010) 0.88
Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study. Eur Respir J (2011) 0.88
Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results. Eur Respir J (2005) 0.88
Evaluation of electrical impedance tomography in the measurement of PEEP-induced changes in lung volume. Chest (1999) 0.87
Stroke volume increase to exercise in chronic obstructive pulmonary disease is limited by increased pulmonary artery pressure. Heart (2008) 0.87
Regional pressure volume curves by electrical impedance tomography in a model of acute lung injury. Crit Care Med (2000) 0.87